Open AccessNovel Approaches to Lymphoma Include New-Generation Anthracycline & Fusion Protein Targeting Il-2 Receptor
Author(s) -
Alice Goodman
Publication year - 2005
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000287220.23357.43
Subject(s) - anthracycline , medicine , cardiotoxicity , lymphoma , oncology , transplantation , clinical trial , cancer , chemotherapy , breast cancer